GeneMind Biosciences Co., Ltd.
PrivateLast Round
Series C
Extension
May 28, 2025
Est. Valuation
$573.5M
Total Funding Raised
$218M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
GeneMind Biosciences Co., Ltd. is a biotechnology company that develops and manufactures DNA sequencing systems and molecular diagnostic technology platforms for clinical and research applications.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Precision Medicine, Biotechnology
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GeneMind Biosciences Co., Ltd. Comparables
Compare GeneMind Biosciences Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cygnus Biosciences (Beijing) Co., Ltd. | 84% | |
| Axbio | 81% | |
| Element Biosciences | 81% | |
GeneMind Biosciences Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | May 28, 2025 | ||||
| Series C | Aug 2, 2023 | ||||
| Series B Extension | Sep 15, 2021 | ||||
| Strategic | Jun 21, 2021 | ||||
| Series B | Sep 1, 2020 | ||||
Series A Extension | Jan 1, 2020 |
Key People
Founding team and executive leadership
GeneMind Biosciences Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sincere Capital | Series B |
| Shenzhen HTI Group | Series C |
| Cowin Capital | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 23, 2026
Grew 19% QoQ, from 53 to 63 employees.
- May 7, 2026
Grew 24% QoQ, from 50 to 62 employees.
GeneMind Biosciences Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GeneMind Biosciences Co., Ltd.'s valuation, stock price, and market status.